OrthoPediatrics Corp. (NASDAQ:KIDS) Shares Acquired by BNP Paribas Financial Markets

BNP Paribas Financial Markets boosted its stake in OrthoPediatrics Corp. (NASDAQ:KIDS) by 125.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,471 shares of the company’s stock after purchasing an additional 1,929 shares during the period. BNP Paribas Financial Markets’ holdings in OrthoPediatrics were worth $94,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the stock. International Assets Investment Management LLC grew its stake in shares of OrthoPediatrics by 2,610.8% in the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock valued at $27,000 after buying an additional 966 shares in the last quarter. Quest Partners LLC purchased a new position in OrthoPediatrics in the 2nd quarter worth approximately $34,000. SG Americas Securities LLC acquired a new stake in OrthoPediatrics in the second quarter valued at approximately $110,000. Quantbot Technologies LP raised its stake in shares of OrthoPediatrics by 42.2% during the third quarter. Quantbot Technologies LP now owns 5,773 shares of the company’s stock valued at $157,000 after purchasing an additional 1,712 shares during the period. Finally, Deerfield Management Company L.P. Series C acquired a new position in shares of OrthoPediatrics during the second quarter worth $203,000. 69.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on KIDS shares. Needham & Company LLC reaffirmed a “buy” rating and set a $42.00 price target on shares of OrthoPediatrics in a research note on Friday, November 8th. JMP Securities reiterated a “market outperform” rating and issued a $50.00 price target on shares of OrthoPediatrics in a research note on Friday, September 13th. Finally, Truist Financial lowered their price objective on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a research note on Wednesday.

OrthoPediatrics Stock Performance

Shares of OrthoPediatrics stock opened at $22.33 on Thursday. The firm has a market cap of $540.74 million, a PE ratio of -18.15 and a beta of 1.14. OrthoPediatrics Corp. has a 1 year low of $21.02 and a 1 year high of $36.23. The firm’s 50-day simple moving average is $25.38 and its 200-day simple moving average is $28.30. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.